Stable nanoparticulate drug suspension

Details for Australian Patent Application No. 2010260226 (hide)

Owner Abbott Laboratories

Inventors Gokhale, Rajeev; Marsh, Kennan C.; Shi, Yi

Agent Spruson & Ferguson

Pub. Number AU-A-2010260226

PCT Pub. Number WO2010/147899

Priority 61/218,281 18.06.09 US

Filing date 14 June 2010

Wipo publication date 23 December 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 31/5377 (2006.01)

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2010/147899 Priority application(s): WO2010/147899

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010260227-Improvement of long chain omega-3 and omega-6 polyunsaturated fatty acid biosynthesis by expression of acyl-CoA lysophospholipid acyltransferases

2010260221-Shared registration system multi-factor authentication